Skip to main content
Top
Published in: Clinical Rheumatology 10/2020

01-10-2020 | Systemic Sclerosis | Letters of Biomedical and Clinical Research

Distinct gene network in skin lesion of patients with diffuse cutaneous systemic sclerosis

Author: Jun Inamo

Published in: Clinical Rheumatology | Issue 10/2020

Login to get access

Excerpt

Diffuse cutaneous systemic sclerosis (dcSSc) is an autoimmune disease characterized by fibrosis and high morbidity and mortality. Progression of skin lesion is associated with subsequent progression of visceral organ lesion and high mortality, suggesting critical disorder may be shared among various lesions [1]. Thus, skin biopsy has been conducted to explore the key molecule in the pathogenesis of dcSSc in situ. Recent studies revealed that fibro-inflammatory pathways were dysregulated in skin lesion by transcriptome profiling [2, 3]. However, these results were based on expression levels of single molecules. To understand the pathogenesis of dcSSc correctly, remaining challenges include how to best identify genes of interest from large datasets. Weighted gene co-expression network analysis (WGCNA) is a system biology method and widely used for finding gene clusters (modules) of highly correlated genes by summarizing such clusters using the module eigengene [4]. Correlation networks facilitate network-based gene screening that can be used to identify candidate biomarkers or therapeutic targets. …
Appendix
Available only for authorised users
Literature
1.
go back to reference Clements PJ, Hurwitz EL, Wong WK, Seibold JR, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA, Steen VD, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Furst DE (2000) Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum 43:2445–2454CrossRef Clements PJ, Hurwitz EL, Wong WK, Seibold JR, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA, Steen VD, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Furst DE (2000) Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum 43:2445–2454CrossRef
2.
go back to reference Assassi S, Swindell WR, Wu M, Tan FD, Khanna D, Furst DE, Tashkin DP, Jahan-Tigh RR, Mayes MD, Gudjonsson JE, Chang JT (2015) Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis. Arthritis Rheumatol 67:3016–3026CrossRef Assassi S, Swindell WR, Wu M, Tan FD, Khanna D, Furst DE, Tashkin DP, Jahan-Tigh RR, Mayes MD, Gudjonsson JE, Chang JT (2015) Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis. Arthritis Rheumatol 67:3016–3026CrossRef
3.
go back to reference Skaug B, Khanna D, Swindell WR, Hinchcliff ME, Frech TM, Steen VD, Hant FN, Gordon JK, Shah AA, Zhu L, Zheng WJ, Browning JL, Barron AMS, Wu M, Visvanathan S, Baum P, Franks JM, Whitfield ML, Shanmugam VK, Domsic RT, Castelino FV, Bernstein EJ, Wareing N, Lyons MA, Ying J, Charles J, Mayes MD, Assassi S (2020) Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile. Ann Rheum Dis 79:379–386CrossRef Skaug B, Khanna D, Swindell WR, Hinchcliff ME, Frech TM, Steen VD, Hant FN, Gordon JK, Shah AA, Zhu L, Zheng WJ, Browning JL, Barron AMS, Wu M, Visvanathan S, Baum P, Franks JM, Whitfield ML, Shanmugam VK, Domsic RT, Castelino FV, Bernstein EJ, Wareing N, Lyons MA, Ying J, Charles J, Mayes MD, Assassi S (2020) Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile. Ann Rheum Dis 79:379–386CrossRef
4.
go back to reference Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9:559CrossRef Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9:559CrossRef
5.
go back to reference Mastrogiannaki M, Lichtenberger BM, Reimer A, Collins CA, Driskell RR, Watt FM (2016) β-Catenin stabilization in skin fibroblasts causes fibrotic lesions by preventing adipocyte differentiation of the reticular dermis. J Investig Dermatol 136:1130–1142CrossRef Mastrogiannaki M, Lichtenberger BM, Reimer A, Collins CA, Driskell RR, Watt FM (2016) β-Catenin stabilization in skin fibroblasts causes fibrotic lesions by preventing adipocyte differentiation of the reticular dermis. J Investig Dermatol 136:1130–1142CrossRef
6.
go back to reference Patel CH, Leone RD, Horton MR et al (2019) Targeting metabolism to regulate immune responses in autoimmunity and cancer. Nat Rev Drug Discov 18:669–688CrossRef Patel CH, Leone RD, Horton MR et al (2019) Targeting metabolism to regulate immune responses in autoimmunity and cancer. Nat Rev Drug Discov 18:669–688CrossRef
Metadata
Title
Distinct gene network in skin lesion of patients with diffuse cutaneous systemic sclerosis
Author
Jun Inamo
Publication date
01-10-2020
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 10/2020
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05245-7

Other articles of this Issue 10/2020

Clinical Rheumatology 10/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.